EO 14200
Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Economy & TradeNational Security
Ad Space (leaderboard)
Summary
This executive order amends a previous order from February 1, 2025 that imposed duties on synthetic opioids from China. It modifies the duty-free de minimis treatment rules for covered articles, making this exemption contingent upon the Secretary of Commerce notifying the President that adequate systems are in place to fully process and collect tariff revenue.
Key Points
- 1Modifies subsection (g) of section 2 of the February 1, 2025 executive order on synthetic opioid duties
- 2Duty-free de minimis treatment for covered articles remains available initially but ceases once the Secretary of Commerce confirms adequate tariff collection systems are operational
- 3The change affects the threshold below which imported covered articles would normally avoid tariff collection due to processing costs
This summary is for informational purposes only. It may not capture all nuances of the executive order. Always refer to the official text for authoritative information.
Ad Space (rectangle)